nialamide has been researched along with scopolamine hydrobromide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Boissier, JR; Dumont, C; Oberlander, C; Peterfalvi, M | 1 |
| Eichhorn, A; Schmutzler, F | 1 |
| Jonas, W; Scheel-Krüger, J | 1 |
| Fog, RL; Pakkenberg, H; Randrup, A | 1 |
| Bhargava, LP; Dandiya, PC | 1 |
2 review(s) available for nialamide and scopolamine hydrobromide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Antiparkinson agents. 50].
Topics: Atropine; Dihydroxyphenylalanine; Diphenhydramine; Histamine H1 Antagonists; Humans; Mephenesin; Monoamine Oxidase Inhibitors; Nialamide; Parasympatholytics; Parkinson Disease; Phenothiazines; Propranolol; Pyridoxine; Scopolamine | 1970 |
5 other study(ies) available for nialamide and scopolamine hydrobromide
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Pharmacological interactions with circling behaviour induced by the piperidinyl indole derivative RU 23686.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Caffeine; Drug Interactions; Haloperidol; Humans; Indoles; Male; Methyltyrosines; Methysergide; Motor Activity; Neurotransmitter Agents; Nialamide; Phenoxybenzamine; Propranolol; Rats; Reserpine; Scopolamine; Stereotyped Behavior | 1977 |
Pharmacological studies on tetrabenazine-induced excited behaviour of rats pretreated with amphetamine or nialamide.
Topics: Animals; Behavior, Animal; Dextroamphetamine; Drug Synergism; Ergotamine; Germ-Free Life; Haloperidol; Humans; Locomotion; Male; Methyltyrosines; Mice; Nialamide; Norepinephrine; Perphenazine; Phenoxybenzamine; Receptors, Cholinergic; Reserpine; Scopolamine; Stereotyped Behavior; Tetrabenazine | 1973 |
Aminergic mechanisms in corpus striatum and amphetamine-induced stereotyped behaviour.
Topics: Animals; Atropine; Basal Ganglia; Behavior, Animal; Catecholamines; Dextroamphetamine; Dopamine; Methyltyrosines; Nialamide; Parasympatholytics; Psychopharmacology; Rats; Scopolamine; Stereotaxic Techniques | 1967 |
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine Oxidase Inhibitors; Nialamide; Nicotine; Nortropanes; Pargyline; Parkinson Disease; Parkinson Disease, Secondary; Perphenazine; Phenelzine; Physostigmine; Rats; Scopolamine; Sulfonic Acids; Tolazoline; Tremor; Tremorine; Trihexyphenidyl; Tryptamines | 1968 |